About
At TRILIO-Medical, we are redefining the standard of care for patients suffering from tricuspid regurgitation (TR) — a condition historically overlooked and under-treated. Our mission is to treat the untreatable and propose a superior TTVI solution. We aim to simplify transcatheter tricuspid repair with an intuitive, easy-to-use system designed for fast adoption and consistent results. Our novel implant provides full coverage of both central and eccentric tricuspid regurgitation, ensuring effective treatment across a wide range of anatomies. The anatomy-preserving structure was designed to maintain native leaflet integrity, reducing procedural complexity and risk. Our system is fully repositionable and retrievable, offering physicians greater control and safety during the procedure. TRILIO empowers more physicians to treat more patients—simply, safely, and effectively.
Technologies
Keywords
Company Information
-
Employees 2
-
Founded 2022
Location
проспект Ариел Шарон, Or Yehuda, Tel Aviv District, Israel, 60000